Visit the main HIFA website:

Drug packaging in 2013: small changes would reap big benefits

Prescrire. Drug packaging in 2013: small changes would reap big benefits. Prescrire 2014
Abstract / Summary: 
ABSTRACT - Drug packaging is important both in protecting and informing patients. Some improvements were made in 2013, but many of the products examined by Prescrire still had poor-quality or even dangerous packaging. - Problem packaging is a major concern for patients who are more vulnerable to adverse effects, particularly children and pregnant women. Several problems were noted with products intended for self-medication (umbrella brands), oral solutions sold with dosing devices, and injectable drugs. - Looking back at 20 years of Red Cards that Prescrire has issued to products with dangerous packaging reveals several improvements, but too many dangers persist. - Urgent action needs to be taken by regulatory agencies and drug companies: patient leaflets must be more explicit with regard to adverse effects, especially those of nonsteroidal anti-inflammatory drugs during pregnancy; accidental ingestion by children must be prevented; and companies must design safer dosing devices. - Healthcare professionals and patients must remain vigilant and report all packaging issues to the relevant authorities. [review appears to refer mainly/exclusively to HICs]  
Users of healthcare information: 
Full text access?: 
Formal literature type: 
Journal title: 
Free Keywords: 


Year published: 
Month published: